Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advicenne SA

advicenne.com/en

Latest From Advicenne SA

Advicenne Prepares For Launch As Rare Kidney Disease Drug Is Filed In The EU

Having had a bid for accelerated assessment rejected by the EMA last year, the French biotech is getting a standard review for ADV7103 in dRTA patients and hopes to launch late 2020.

Rare Diseases Renal

Stemline  Has What It Takes On EU Fast-Track Front  

There's good news for Stemline Therapeutics on the EU fast-track front. At least three other companies, though, have had their requests rejected in recent months and Novartis is not saying whether a request it made was successful or not.

Europe BioPharmaceutical

EU Accelerated Assessment Tracker: Second Half Trumps First By Far

The first half of the year was pretty bleak for companies seeking fast-track review of their products in the EU. There has been much better news in the second half. The Pink Sheet tracks the winners and losers.

Europe Review Pathway

MedinCell Boosts Funding For Long-Acting Injectables Portfolio

France's long-acting injectables technology company, MedinCell, which is collaborating with Teva on a Phase III long-acting risperidone formulation, has completed an IPO on Euronext Paris, giving a lift to its development plans.

 

Neurology Financing
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Advicenne SA
  • Senior Management
  • Luc-André Granier, MD, PhD, CEO & Med. Dir.
    Caroline Roussel-Maupetit, Dir., Operations
    Catherine Guittet, PhD, Dir., Clinical Research & Reg. Affairs
    Catherine Martre, Head, Strategy & Comm. Dev.
  • Contact Info
  • Advicenne SA
    Phone: 466 05 54 20
    2, rue Briçonnet
    Nîmes, F-30 000
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register